| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |